<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01023971</url>
  </required_header>
  <id_info>
    <org_study_id>Trust R&amp;D_3704</org_study_id>
    <nct_id>NCT01023971</nct_id>
  </id_info>
  <brief_title>Macular Function During Anti-VEGF Treatment</brief_title>
  <acronym>MAFAT</acronym>
  <official_title>Study of Macular Function During Anti-VEGF Treatment</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Royal Liverpool University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Royal Liverpool University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine the changes in macular function during anti-VEGF
      treatment for neovascular age-related macular degeneration.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Macular function will be investigated using visual acuity, contrast sensitivity, mfERG and
      microperimetry.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>January 2009</start_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>mfERG central ring amplitude density</measure>
    <time_frame>12 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Mean retinal sensitivity (dB) in three concentric rings (4°, 8° &amp; 12°)</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Choroidal blood flow (ChBFlow) at fovea and at optic nerve head</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Age Related Macular Degeneration</condition>
  <arm_group>
    <arm_group_label>Group A</arm_group_label>
    <description>Patients investigated with mfERG and MP-1</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group B</arm_group_label>
    <description>Patients investigated by Laser Doppler Flowmetry</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        AMD clinic
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Neovascular AMD in first or second eyes

          -  angiographic signs of active subfoveal or juxtafoveal choroidal neovascularization
             (CNV)

          -  BCVA ≥35 ETDRS letters

        Exclusion Criteria:

          -  Spherical equivalent ≥ ± 6 D

          -  Previous treatments for CNV in the studied eye
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Simon P HARDING, FRCOphth, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Liverpool</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Simon P Harding, FRCOphth, MD</last_name>
    <phone>+44 0151 706</phone>
    <phone_ext>3966</phone_ext>
    <email>S.P.Harding@liverpool.ac.uk</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Claudio S Campa, MD, PhD</last_name>
    <phone>+44 0151 706</phone>
    <phone_ext>3939</phone_ext>
    <email>Claudio.Campa@rlbuht.nhs.uk</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Clinical Eye Research Centre</name>
      <address>
        <city>Liverpool</city>
        <zip>L7 8XP</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Simon P HARDING, FRCOphth, MD</last_name>
      <email>S.P.Harding@liverpool.ac.uk</email>
    </contact>
    <investigator>
      <last_name>SIMON P HARDING, FRCOphth, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>CLAUDIO S CAMPA, MD,PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>December 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 1, 2009</study_first_submitted>
  <study_first_submitted_qc>December 1, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 2, 2009</study_first_posted>
  <last_update_submitted>December 1, 2009</last_update_submitted>
  <last_update_submitted_qc>December 1, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 2, 2009</last_update_posted>
  <responsible_party>
    <name_title>Simon P Harding</name_title>
    <organization>Royal Liverpool University Hospital</organization>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Macular Degeneration</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bevacizumab</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

